Leave a message

Multisystem Inflammatory Syndrome in Neonates; a Real Diagnostic Dilemma!

case report | DOI: https://doi.org/10.31579/2692-9392/128

Multisystem Inflammatory Syndrome in Neonates; a Real Diagnostic Dilemma!

  • Bandara S 1
  • Bavanandan B 2
  • Karunarathna W.A.C.N 2
  • Attanayake J.C3 3

1Consultant Paediatrician, Incharge - Neonatal unit, Teaching hospital, Peradeniya, Sri Lanka.
2Registrar in Paediatrics, Neonatal intensive care unit, Teaching hospital, Peradeniya, Sri Lanka. 
3Medical Officer, Neonatal intensive care unit, Teaching hospital, Peradeniya, Sri Lanka. 

*Corresponding Author: Sandhya bandara, Consultant Paediatrician Incharge Neonatology unit Teaching Hospital, Peradeniya.

Citation: Bandara S, Bavanandan B, Karunarathna W.A.C.N, Attanayake J.C. (2022) Multisystem Inflammatory Syndrome in Neonates; a Real Diagnostic Dilemma!. J. Archives of Medical Case Reports and Case Study, 6(1); DOI: 10.31579/2692-9392/128

Copyright: © 2022 Balasubramaniyam Bavanandan, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 23 May 2022 | Accepted: 10 June 2022 | Published: 28 June 2022

Keywords: neonatal multisystem inflammatory syndrome; early onset sepsis; SARS-Co-2; immune dysregulation; immune modulatory therapy

Abstract

Neonatal multisystem inflammatory syndrome is a potentially life threatening disease entity which was described following the global crisis of SARS-CoV-2 that still demands further evidence for a conclusive diagnosis. We report a group of neonates who admitted to our neonatal intensive care unit with predominantly cardiac manifestations were treated for early onset of sepsis and subsequently for Neonatal multisystem inflammatory syndrome ended up with a good survival outcome. 

Abbreviations

IgM – Immunoglobulins M

IgG – Immunoglobulins G 

MIS-C – Multisystem inflammatory syndrome in children 

RT-PCR – Reverse transcriptase polymerase chain reaction 

QTc – Corrected QT interval 

MOD – Mode of delivery 

NVD –Normal vaginal delivery 

LSCS – Lower segment caesarian section 

EM – Emergency 

EL – Elective 

HVS – High vaginal swab 

GBS – Group B streptococcus 

UTI – Urinary tract infection 

POA – Period of amenorrhea 

IV IG – Intravenous immunoglobulins 

IV MP – Intravenous Methyl prednisolone 

MRSA – Methicillin resistant staphylococcus aureus 

EF – Ejection fraction 

Introduction 

COVID-19 caused by SARS-CoV-2, is a global public health crisis with the significant surge in Sri Lanka. According to the figures from Health Promotion Bureau, Sri Lanka, as of 9 may 2022, 517 million individuals were infected worldwide and six hundred thousand were infected in Sri Lanka. Initial studies showed that children were spared of severe COVID-19 [1-3]. However, recently many case reports of children experiencing a potentially life threatening multisystem inflammatory syndrome in children (MIS-C) has been explained [4-6]. 

MIS-C is said to be due to immune dysregulation following exposure to SARS-CoV-2 though the exact mechanism is still unclear [7]. It presents with fever with multi organ involvement, with raised inflammatory markers weeks after exposure to SARS-CoV-2 (4,5,7). MIS-C has clinical and biochemical resemblance with Kawasaki disease and severe COVID-19 cytokine storm seen in adults [8]. However, its pathophysiology is somewhat different and may be mediated by autoantibodies formed following a COVID-19 infection [9]. More than 80% of children with MIS-C have positive serology (Specific IgM and IgG antibodies) against SARS-CoV-2, but only about one third are positive for SARS-CoV-2 by RT-PCR [4,10,11]. 

Unlike MIS-C, where the primary infection and multisystem inflammation occur in the same subject, few case reports suggest neonatal multisystem inflammation (MIS-N) occurs secondary to maternally derived antibodies against SARS-CoV-2 which were believed to occur in the newborn through trans-placental passage [13-16].

Maternal antibodies pass transplacentally is a well-known fact and maternal infection with SARS-CoV-2 is not different. Multiple studies are reported transplacental transfer of anti SARS-CoV-2 IgG antibodies to neonates [17-19]. The majority (87%) of infants born to seropositive mothers had detectable IgG antibodies at birth and there was a positive correlation with maternal and infant antibody titers, regardless of presence of symptoms in the mother [18]. 

Few Indian case series described that these neonates mainly presented with conduction system abnormalities with structurally normal hearts. Specifically prolonged QTc with atrioventricular block or thrombosis with in the 1st week after birth [20].

We present a case series of a group of newborns who admitted to our neonatal intensive care unit over the period of 6 months (1st October 2021 to 31st march 2022) with predominantly cardiac manifestations were treated for early onset of sepsis and subsequently for Neonatal multisystem inflammatory syndrome, ended up with a survival outcome of 87.5% without major comorbidities. 

Case details are summarized in table 1. 

Case number SexPOA  Parity  MOD  Birth weight Birth asphyxia Antenatal history Perinatal history Fetal scan 
1Female  37  P2C1NVD2.5kg  No  No  NoNormal  
2Female  39P5C3NVD3.3kgNoNoNoNormal
3Female  41P3C2Assisted vaginal delivery 3.1kgNo  NoDribbling for unknown duration Normal  
4Female  40P1C0EM/LSCS  3.2kgNoNoModerate meconium, dribbling for 14 hours, HVS – GBS positive Normal  
5Female  38P2C1EL/LSCS  3.3kgNoNoNoNormal  
6Female  40P1C0  NVD  2.75kg  No  NoModerate meconium Normal  
7Male  39  P1C0EM/LSCS  3.85kg  NoNo  Dribbling 28 hours Normal  
8Female  30  P1C0  NVD  1.4kg  NoUTI  No  Normal  

Maternal features

Of the eight mothers (all with singleton pregnancy), two (25%) were symptomatic for COVID-19 during pregnancy, six (75%) were asymptomatic. Both symptomatic mothers were tested positive for Rapid antigen test for COVID-19 during 3rd trimester. All mothers were tested for COVID – 19 Rapid antigen test during the admission for delivery and none of them detected positive. Antenatal scans were normal in all mothers and there were no antenatal complications were recorded either. 

All mothers were vaccinated for COVID – 19 during pregnancy. The details of vaccination are shown in table 2. 

(Table 2)

Case number 

Maternal RT-PCR 

Maternal RAT 

Maternal  

Serology  

Symptoms suggestive of COVID – 19 infection 

Exposure History 

Vaccination status during pregnancy 

Serological evidence in the neonate 

1st dose 

2nd dose 

Booster dose 

1

Not done 

Positive at 28 weeks 

Not done 

Yes  

Yes  

6 weeks 

32 weeks 

Not given

IgG positive

(393AU/ml)

2

No

No  

Not done 

No

No

19 weeks 

23 weeks 

33 weeks 

IgG positive 

(>400AU/ml)

3

Not done 

Positive at 40 weeks

Not done 

Yes

Yes

12 weeks 

16 weeks 

Not given 

IgG positive

(362AU/ml) 

4

No  

No

Not done 

No

No

24 weeks 

28 weeks 

Not given 

IgG positive

 (Titer not available)

5

No

No

Not done 

No

No

18 weeks 

22 weeks 

Not given 

IgG positive

(245AU/ml) 

6

No

No

Not done 

No

No

22 weeks 

26 weeks 

Not given 

IgG positive 

(>100AU/ml)  

7

No

No

Not done 

No

No

22 weeks 

26 weeks 

Not given 

IgG positive 

(274AU/ml)

8

No

No

Not done 

No

No

23 weeks 

27 weeks 

Not given 

IgG positive (Titer not available) 

Resuscitation at birth and post resuscitation period 

Three neonates (37.5%) did not cry immediately after birth and two of them had significant respiratory distress in the delivery room. But none of them require any positive pressure ventilation in the delivery room. However all three required respiratory support in the form of nasal prong oxygen. Five neonates (62.5%) neither required resuscitation nor respiratory support in post resuscitation period. 

Clinical presentation

The most common presentation involved the cardiovascular system. Three had rhythm disorders (37.5%) and all of them presented with prolonged QTc interval. One infant also had an episode of persistent unexplained tachycardia. Hypotension was seen in four neonates. Cardiac dysfunction (Septal hypokinesia, dilated cardiac chambers and low ejection fraction) in 2D Echocardiography was seen in 87.5% of neonates. One neonate had slightly prominent right coronary in the 2D Echocardiogram and another one had thin rim of pericardial effusion. One had normal 2D-Echocardiogram. 

Table 3 summarizes the general characteristics and other clinical presentations 

(Table 3)

Characteristic  

Variables  

Percentage  

Total number of cases assessed

Maternal symptoms 

Symptomatic  

Asymptomatic  

 

25%

75%

8

Trimester when the mother had COVID 

1st trimester 

2nd trimester 

3rd trimester 

 

0%

0%

100%

2

Maternal exposure to COVID patients 

Exposure  

No exposure 

Unknown  

 

25%

0%

75%

8

COVID Vaccination status 

1st dose 

 

 

2nd dose 

 

 

Booster dose 

 

 

1st Trimester                           

2nd trimester 

3rd trimester 

1st Trimester 

2nd trimester 

3rd trimester 

1st Trimester 

2nd trimester 

3rd trimester 

 

 

25%

75%

0%

0%

25%

75%

0%

0%

100%

 

 

 

8

 

 

8

 

 

1

Mode of delivery 

NVD  

Assisted vaginal delivery 

EL/LSCS

EM/LSCS  

50%

12.5%

12.5%

25%

 

8

Gestational age at birth 

<28>

28 – 32 weeks 

32+1 – 36+6 weeks 

>37 weeks 

0%

12.5%

0%

87.5%

 

8

Birth weight 

>3.5Kg

2.5Kg – 3.5Kg

1.5Kg – 2.5Kg

< 1>

12.5%

75%

12.5%

0%

 

8

Multiplicity  

Singleton  

Twin  

100%

0%

 

8

Age at presentation 

<24hours>

1 – 5 days

>5days  

37.5%

50%

12.5%

 

8

Organ system involvement 

Cardiac  

Hematologic  

Respiratory  

Gastrointestinal  

Neurologic  

Cutaneous  

Renal  

Fever/Temperature instability 

Antenatal Complications 

 

87.5%

75%

50%

25%

12.5%

0%

12.5%

50%

0%

 

8

8

8

8

8

8

8

8

8

 

Cardiac manifestations 

Bradycardia  

Unexplained tachycardia 

Hypotension & shock 

Prolonged QT interval 

Dilated cardiac chambers 

Dilated coronary arteries 

Tricuspid regurgitation 

Mitral regurgitation 

Pericardial effusion 

Intracardiac thrombosis 

Persistent pulmonary hypertension 

0%

12.5%

50%

37.5%

75%

12.5%

0%

0%

12.5%

0%

12.5%

 

8  

8

8

8

8

8

8

8

8

8

8

Respiratory manifestations 

Respiratory distress 

Pleural effusion 

25%

12.5%

 

8

8

Gastrointestinal manifestations 

Feed intolerance 

Ascites  

12.5%

25%

 

8

8

 

Renal manifestations 

Acute renal failure 

12.5%

 

8

CNS manifestations 

 

Convulsions  

12.5%

8

Four of eight neonates (50%) had at least one indication for intra partum antibiotic prophylaxis to prevent early onset sepsis (21,22). Two of them had dribbling for more than 18 hours, one had high vaginal swab positive for group B streptococcus in current pregnancy and one neonate born prematurely at 30 weeks of gestation in whom the mother had symptomatic culture negative urinary tract infection during antenatal period. 

As five of eight neonates had positive blood cultures (one positive for MRSA and four positive for klebsiella pneumoniae – 62.5%) and all of them had blood pictures positive for possible early onset bacterial sepsis (left shift with neutrophil toxic changes) with elevated inflammatory markers we have considered early onset of sepsis as the primary diagnosis and commenced intravenous antibiotics according to the local guidelines. Neonates who developed circulatory compromise (50%) were effectively managed with intravenous inotropes. 

The higher incidence of cardiac manifestations among this group of neonates which is quite unusual to explain only by early onset of sepsis, urged us to consider cardiac markers and 2D Echocardiography to exclude possible infectious or inflammatory myocarditis in them. Surprisingly all of them had elevated troponin I values for age related ranges with 2D Echocardiographic changes suggestive of ventricular dysfunction after the 1st week of life while on treatment with appropriate antibiotics according to the antibiotic sensitivity test. 

As new cases with asymptomatic COVID-19 infections being soaring up during that period in our country we have also considered Multisystem inflammatory syndrome in new born (MIS-N) induced by trans placental passage of COVID-19 antibodies as an alternative diagnosis. 

To further confirm the diagnosis, investigations done according to the current guidelines for MIS-N practiced in Sri Lanka (Table 4) [23]. 

(Table 4)

Investigations  

Percentage

Total number cases assessed

Neutrophilic leukocytosis 

0%

8

Thrombocytopenia  

75%

8

Elevated C reactive protein 

87.5%

8

Elevated Serum ferritin 

50%  

2

Elevated Pro-calcitonin 

100%

2

Elevated Lactate dehydrogenase 

87.5%

8

Elevated D-dimers 

100%

8

Elevated liver enzymes 

87.5%

8

Elevated Creatinine 

12.5%

8

Elevated INR 

75%

8

Elevated troponin I 

100%

8

Hyponatremia  

12.5%

8

Positive blood culture 

62.5%

8

Positive CSF analysis 

25%  

4  

Blood picture compatible with sepsis 

100%

8

Anti-SARS-CoV-2-IgM antibodies were not done in all the neonates because it is not readily available in Sri Lanka, and IgG antibodies (cut-off-index (COI) > 1 considered reactive) were positive in all neonates. 

The neonates were treated with IVIG (2g/kg over 24 to 48 hours), methylprednisolone (10mg/kg over 30 minutes for 5 days), aspirin (1-5mg/kg/day) and anti-failure treatment (Furosemide and Captopril). The neonates have also been covered with 14 – 21 days of intravenous antibiotics. Normalization of QTc and remarkable improvements in ventricular functions on subsequent 2D Echocardiograms were observed following immune modulatory therapy. 

Table 5 summarizes the cardiac manifestations and the treatment given.

(Table 5)

Case number 

Clinical presentation 

Day of presentation 

Troponin I 

QTc 

(>0.47 - prolonged) 

2-DECHO

 

Treatment given 

1

Persistent tachypnea since birth 

Day 1 

93pg/mL on day 10  

0.40 seconds 

Dilated left ventricle with mild septal hypokinesia (EF – 53%) 

IVIG

IV MP

Captopril

Furosemide 

Aspirin 

Prednisolone 

2

Fever 

Day 2 

63.2pg/mL on day 15 

0.50 seconds 

Mildly prominent left ventricle (EF – 70%) 

IVIG

IV MP

Aspirin

Prednisolone 

3

Fever 

Day 8 

93.9pg/mL on day 19 

0.42 seconds 

Mild fullness of left ventricle (EF – 65%) 

 

IVIG

Aspirin

Prednisolone 

4

Poor feeding 

 

Day 2

195pg/mL on day 20 

 

0.41 seconds 

Fullness of left ventricle with mild septal hypokinesia (EF – 69%)

Prominent right coronary artery 

IVIG

IV MP

Aspirin 

Prednisolone

Furosemide 

spironolactone 

5

Persistent pulmonary hypertension 

Day 2 

75.5pg/mL on day 12 

0.48 seconds 

Mild fullness of left ventricle (EF-76%) 

IVIG

IV MP

Aspirin

Prednisolone

6

Respiratory distress 

Day 1

89.2pg/mL on day 32 

0.43 seconds 

Global hypokinesia, mild ventricular dysfunction 

Thin rim of pericardial effusion (EF-45-50%) 

 

IVIG

IV MP

Captopril

Furosemide 

Aspirin 

Prednisolone

7

Fever 

Day 3 

111.4pg/mL on day 24 

0.48 seconds

Hypokinetic inter ventricular septum

(EF – 48%)

IVIG

IV MP

Captopril

Furosemide 

Aspirin 

Prednisolone

8

Very prematurity 

Day 1 

80.5pg/mL 

 

 

0.42 seconds 

No evidence of myocarditis and coronary arteritis (EF – not available) 

IVIG

IV MP

The only premature baby in this group eventually succumbed due to acute kidney injury related complications. Those term neonates who survived (87.5%) were discharged with aspirin, oral prednisolone and anti-failures and put on follow up at clinic on regular intervals to modify the drug management according to the repeat 2D-Echocardiograms in liaison with pediatric cardiology team.   

Discussion

According to the proposed inclusion criteria for neonatal multisystem inflammatory response syndrome (MIS-N) secondary to maternal SARS-CoV-2 exposure or infection, presence of a positive blood culture excludes the diagnosis of MIS-N [23]. However there were no convincing evidence to describe the cardiac manifestations that we have observed in this group of neonates, caused by sepsis alone. 

Presence of IgG antibodies against COVID-19 in high titers (>100AU/L) and significant improvement observed clinically, biochemically and in follow up 2D-Echocardiograms with immune modulatory therapy further suggest an underlying inflammatory process could be due to MIS-N caused by trans-placental passage of antibodies following symptomatic and asymptomatic COVID-19 infection in the mothers during pregnancy. 

Thus, we believe that the immune dysregulation caused by multisystem inflammatory syndrome may increase the susceptibility to acquire early onset sepsis in newborns and both these entities may coexist in a given time. But we require further evidence to support our observation. 

Conclusion 

The diagnosis of neonatal multisystem inflammatory syndrome following SARS-CoV-2 infection or exposure during antenatal period, is a diagnostic dilemma that demands further studies to understand the underlying pathological mechanism and to decide on crucial immune modulatory therapy in mixed presentations as in our case. 

References

a